ClearPoint Neuro Inc. (CLPT), which has experienced continued growth in product sales and revenue since 2014, is poised for another impressive year ahead.
This global device, cell, and gene therapy-enabling company is comprised of two parts: (i) a business providing medical devices for neurosurgical applications, and (ii) a business focused on partnerships in the biologics and drug delivery space.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com